Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)

Funding Agency:
National Institutes of Health

The purpose of this funding opportunity announcement is to encourage collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem; and 2) integrate, optimize, validate, translate or otherwise accelerate the adoption of promising tools, methods and techniques for a specific research or clinical problem in basic, translational, or clinical science and practice. An application may propose design-directed, developmental, discovery-driven, or hypothesis-driven research and is appropriate for small teams applying an integrative approach to increase our understanding of and solve problems in biological, clinical or translational science.  

Companion FOA:   PAR-19-158 Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)

Deadlines:

  • R01 Deadlines: Feb. 5, Jun. 5, Oct. 5.
  • AIDS Deadlines: Jan. 7, May 7, Sep. 7.

PAR-19-159 Expiration Date: May 8, 2021

Eligibility

Faculty

Category

Engineering and Physical Sciences
Environmental & Life Sciences
Interdisciplinary
Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

October 5, 2019